This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dall, P. Articles by Herrlich, P. Search for Related Content PubMed PubMed Citation Articles by Dall, P. Articles by Herrlich, P.

Surface Protein Expression and Messenger RNA-splicing Analysis of CD44 in Uterine Cervical Cancer and Normal Cervical Epithelium¹

Kernforschungszentrum Karlsruhe, Institut für Genetik, P. O. Box 3640, D-76021 Karlsruhe [P. D., K-H. H., A. H., H. P., P. H.], and Universität Heidelberg, Universitätsfrauenklinik, D-69155 Heidelberg [G. v. M., M. K.], Germany

Variant CD44 has recently been shown to serve as a metastasis marker in human breast cancer. Certain variant epitopes on primary tumors predict poor survival probabilities for the patients. In this study, immunohistochemical analysis of 16 uterine cervical carcinomas showed strong expression of several CD44 variant epitopes in all samples. In normal cervical epithelia from 5 patients, expression of these epitopes was restricted to particular cell layers, with expression being strong in basal and spinal cells but absent in superficial cells. Fifteen of 16 cancer samples were stained strongly with an antibody which recognizes one particular CD44 epitope that is encoded by both variant exons v7 and v8. This epitope was not detectable in normal cervical epithelium. CD44-mRNA splicing analysis showed qualitative and quantitative differences between malignant and normal tissues with a much more complex splice pattern and high expression of a large CD44 isoform containing variant exons v3 to v10 (including the v7/v8 transition epitope) in about one-half of the cancer samples. Interestingly, patients with lymph node metastases were in this group only. These differences in CD44 epitope expression and mRNA splicing in cervical carcinoma reveal dynamic changes in CD44 expression during carcinogenesis. Such changes could provide metastatic cells with a selective advantage during the carcinogenic process. Furthermore, the v7/v8 epitope may be suitable for screening early stages of cervical cancer.

¹ This work was supported by Grants Da 327/1-1 and He 551/7-1 from the Deutsche Forschungsgemeinschaft.

² To whom requests for reprints should be addressed.

Received 2/17/94. Accepted 5/19/94.

This article has been cited by other articles:

				A. Wibulswas, D. Croft, I. Bacarese-Hamilton, P. McIntyre, E. Genot, and I. M. Kramer The CD44v7/8 Epitope as a Target to Restrain Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis Am. J. Pathol., December 1, 2000; 157(6): 2037 - 2044. [Abstract] [Full Text] [PDF]

				A. C. Woodman, S. Goodison, M. Drake, J. Noble, and D. Tarin Noninvasive Diagnosis of Bladder Carcinoma by Enzyme-linked Immunosorbent Assay Detection of CD44 Isoforms in Exfoliated Urothelia Clin. Cancer Res., June 1, 2000; 6(6): 2381 - 2392. [Abstract] [Full Text]

				L. Rodriguez-Rodriguez, I. Sancho-Torres, D. G. Gibbon, L. F. Miller Watelet, and C. Mesonero CD44-9v and CD44-10v Are Potential Molecular Markers for Squamous Cell Carcinoma of the Vulva Reproductive Sciences, January 1, 2000; 7(1): 70 - 75. [Abstract] [PDF]

				S. Goodison, K. Yoshida, M. Churchman, and D. Tarin Multiple Intron Retention Occurs in Tumor Cell CD44 mRNA Processing Am. J. Pathol., October 1, 1998; 153(4): 1221 - 1228. [Abstract] [Full Text] [PDF]